Bookedited by Eric Hollander, Randi J. Hagerman, Casara Jean Ferretti.
Summary: "More than 40 years after the official recognition of infantile autism in DSM-III, advances continue to be made in our understanding of the possible causes, assessment and evaluation, and treatment of autism spectrum disorder (ASD). With contributions by dozens of experts in the field, this second edition of the Textbook of Autism Spectrum Disorders has been updated to reflect the latest research in ASD. Unrivaled in its thoroughness, this volume discusses issues of assessment and evaluation; examines the etiology of ASD and its recognized associations with other medical conditions; analyzes standard and experimental treatments; and delves into social policy issues pertinent to individuals with ASD and those who treat them. With summary points in each chapter and copious lists of recommended readings, this is an indispensable resource for psychiatrists, psychologists, neurologists, social workers, speech therapists, educators, and all others in the continuum of care"-- Provided by publisher.
Contents:
Cover
Half Title
Title
Copyright
Contents
Contributors List
Foreword
PART I: Assessment, Evaluation, and Target Symptoms
Part 1A: AASSESSMENT AND EVALUATION
1 Epidemiology
2 Psychiatric Assessment and Treatment
3 Pediatric and Neurological Assessments
4 Gender Dysphoria, Gender Incongruence, and Sexual Identity
5 Racial and Ethnic Disparities in Assessment and Evaluation
6 Digital Biomarkers in Diagnostics and Monitoring
Part 1B: TARGET AND COMORBID SYMPTOMS
7 Social Communication
8 Diet and Nutrition
PART II: Causes
Part IIA: OVERVIEW 9 Genetics and Genomics
10 Epigenomics
11 Prenatal, Perinatal, and Parental Risk Factors
12 Animal Models
13 Electrophysiological Studies
14 Environmental Toxicity and Immune Dysregulation
Part IIB: SYNDROMIC CAUSES
15 Overview of Syndromic Causes of ASD and Commonalities in Neurobiological Pathways
16 Fragile X Syndrome and Associated Disorders
17 Tuberous Sclerosis Complex
18 16p11.2 and Other Recurrent Copy Number Variants Associated With ASD Susceptibility
19 Rett Syndrome
20 Prader-Willi Syndrome
Part IIC: IMAGING AND ANATOMY 21 Neuroanatomical Findings
22 The Amygdala in ASD
23 Neurobiology of ASD Informed by Structural Imaging Research
24 Positron Emission Tomography
25 Functional Magnetic Resonance Imaging
PART III: Treatments and Interventions
Part IIIA: STANDARD PHARMACOLOGICAL TREATMENTS
26 Serotonergic Medication
27 Antipsychotics
28 Treating Hyperactivity in Children With Pervasive Developmental Disorders
Part IIIB: EXPERIMENTAL THERAPEUTICS
29 Complementary and Integrative Approaches
30 Oxytocin
31 Vasopressin
32 N-Acetylcysteine 33 Arbaclofen: From Animal Models to Clinical Trials
34 Cannabis, Cannabinoids, and Immunomodulatory Agents
Part IIIC: BEHAVIORAL AND EDUCATIONAL INTERVENTIONS
35 Behavioral Treatments
36 Early Start Denver Model
37 The Developmental, Individual Difference, Relationship-Based Intervention Model: A Comprehensive Parent-Mediated Approach
38 School-Based Interventions
39 Language and Communication: Challenges and Treatments
Part IIID: FUTURE TREATMENT DEVELOPMENTS
40 Transcranial Magnetic Stimulation
41 Stem Cell and Gene Therapy 42 Gene Therapy and Molecular Interventions
PART IV: Consortiums, Employment, and Advocacy
43 Consortiums
Developing Precision Medicine Approaches to ASD
Autism Biomarkers Consortium for Clinical Trials
Interactive Autism Network
44 Autism Strengths and Neurodiversity
45 Role of Patient Advocacy Groups in Treatment Development
Index
Plates
Back Cover